Karel P.
- Country
- Czechia
- Department
- N/A
Research Overview
- A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
- A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period
- A Randomized, Multi-regional, Double-blind, Double-dummy Parallel-group, Placebo and Allopurinol-controlled Phase 3 Study to Assess the Efficacy and Safety of Tigulixostat in Gout Patients with Hyperuricemia
Data & Insights
Has run more than one trial at 77 of 254 partner sites.
Specializations
Inflammatory Arthritis
Focused investigation of rheumatoid arthritis and psoriatic arthritis treatments, particularly evaluating novel therapeutic approaches for patients with inadequate response to conventional treatments.
- Treatment-resistant rheumatoid arthritis
- Psoriatic arthritis management
- JAK inhibitor therapies
Expertise in assessing innovative treatment modalities for inflammatory joint conditions.
Spondyloarthropathies
Specialized research in axial spondyloarthritis and its variants, including both radiographic and non-radiographic forms. Evaluation of targeted biological therapies for spine and joint inflammation.
- Non-radiographic axial spondyloarthritis
- Ankylosing spondylitis
- Biologic therapy assessment
Focus on long-term disease management and remission maintenance strategies.
Degenerative Joint Conditions
Expert investigation of osteoarthritis treatments, particularly focusing on knee osteoarthritis and innovative therapeutic approaches. Research includes both conventional and novel treatment modalities.
- Knee osteoarthritis interventions
- Structural joint modification
- Pain management strategies
Emphasis on developing treatments for symptomatic joint disease and structural improvement.
Metabolic Rheumatic Diseases
Investigation of gout with hyperuricemia and related metabolic conditions, evaluating comparative efficacy of various therapeutic approaches.
- Hyperuricemia management
- Urate-lowering therapies
- Comparative treatment studies
Focus on optimizing treatment outcomes in metabolic rheumatic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.